Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible

Uyanık, Sadık Ahmet; Öğüşlü, Umut; Aminu, Ibrahim Sani; Yılmaz, Birnur; Çevik, Halime; Atlı, Eray; Gümüş, Burçak

doi:10.2214/ajr.20.23023

Cited by 12 publications

(6 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The advantage of ER includes minimal invasion, fewer complications, and a simple operative procedure. However, the main ER defect is symptom recurrence, with a reintervention rate of up to 28.3−62.8% as reported 7,10,21–23 …”

Section: Discussionmentioning

confidence: 93%

“…7,8 Endovascular recanalization (ER) has been proven to be a feasible method for TAO patients with severe limb ischemia by several retrospective reports. 7,[9][10][11] Compared with bypass surgery, the inadequacy of ER mainly lies in a high rate of reintervention. These intractable therapy problems render TAO progress little during its century history.…”

Section: Introductionmentioning

confidence: 99%

“…Arterial bypass with autogenous veins is regarded as an ideal recanalization strategy with high amputation‐free survival and patency rate; however, due to its small artery involvement, more than 80% infrapopliteal outflow is unsuitable for the bypass surgery 7,8 . Endovascular recanalization (ER) has been proven to be a feasible method for TAO patients with severe limb ischemia by several retrospective reports 7,9–11 . Compared with bypass surgery, the inadequacy of ER mainly lies in a high rate of reintervention.…”

Section: Introductionmentioning

confidence: 99%

“…Currently, the feasibility and effectivity of autogenous venous bypass and ER have been complications, and a simple operative procedure. However, the main ER defect is symptom recurrence, with a reintervention rate of up to 28.3−62.8% as reported 7,10,[21][22][23]. The pathology of TAO may be an essential reason for the symptom recurrence and the high reintervention rate.…”

mentioning

confidence: 98%

See 3 more Smart Citations

Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience

Xue,

Zhang,

Peng

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

Background and AimsEndovascular recanalizaiton (ER) has been proven to be a feasible method for Thromboangiitis Obliterans (TAO). The aims of this study were to evaluate the effectiveness and safety of atherectomy for TAO compared to nonatherectomy ER in our center.MethodsPatients diagnosed as TAO were reviewed from January 2016 to June 2021 in our center. Basic characteristics of patients before ER and perioperative data were collected and compared between the atherectomy and nonatherectomy groups. The vascular event‐free survival and limb salvage were calculated to evaluate the prognosis of TAO patients after ERs. Logistic Regression and Cox Regression were used to identify the risk factors for technical failure and prognosis, respectively.ResultsSeventy‐two TAO patients with 79 lower limbs who met the criteria were included in this report. Compared with the nonatherectomy group, no significant improvement was identified in ER technical success, vascular event‐free survival, or limb salvage in the atherectomy group. The total technical success rate was 91.1% (atherectomy group, 95.2%; nonatherectomy group, 89.7%), and the multiple limb involvement (p = 0.005; odds ratio [OR], 28.16; confidence interval [CI], 3.28−241.55) was the independent risk factor for technical failure. The total vascular event‐free survival proportion was 66.05% and 58.40% at 1 and 3 years, respectively. Technical failure (OR, 5.61; 95% CI, 1.57−20.04; p = 0.008), and runoff grade 0 (OR, 3.28; 95% CI, 1.09−9.85; p = 0.034) were independent risk factors for vascular events. The total limb salvage proportion at 1 and 3 years was 95.84% and 92.53%, respectively. Technical failure (OR, 8.54; 95% CI, 1.71−40.73; p = 0.02) was identified as an independent risk factor for above ankle amputation.ConclusionsNo significant difference in prognosis was found between the atherectomy group and the nonatherectomy group during a midterm follow‐up. The technical success of ER was crucial for TAO prognosis.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 98%

See 2 more Smart Citations

Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience

Xue,

Zhang,

Peng

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…However, there is still no consensus regarding the treatment of CLI due to TAO, except for smoking cessation 16) . Although the current guidelines recommend the use of revascularization strategies such as endovascular intervention and arterial reconstructive surgery for atherosclerotic CLI, the aforementioned therapies may be technically challenging for patients with TAO because of the location of lesions in the distal vessels or lack of target vessels 17) .…”

Section: Discussionmentioning

confidence: 99%

Critical Limb Ischemia due to Buerger Disease Successfully Treated with Endovascular Recanalization and Distal Bypass

Kitai,

Kanayama,

Suhara

et al. 2023

International Journal of Surgical Wound Care

View full text Add to dashboard Cite

Buerger disease or thromboangiitis obliterans is a non-atherosclerotic, segmental, inflammatory, peripheral arterial occlusive disease in young male smokers. Revascularization via endovascular treatment and/or bypass surgery is less common and is technically challenging in patients with Buerger disease. Herein, we report the case of a 30-year-old male patient who underwent endovascular treatment followed by bypass surgery, which successfully salvaged his critically ischemic limbs. This case demonstrates that a revascularization strategy for critical limb ischemia due to Buerger disease could be beneficial for limb salvage. To achieve effective limb salvage, a collaborative approach among endovascular specialists, vascular surgeons, and reconstructive surgeons is recommended.

show abstract

Endovascular treatment for thromboangiitis obliterans (Buerger’s disease)

Carneiro

Almeida

Cacione

2023

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible

Cited by 12 publications

References 27 publications

Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience

Assessment of atherectomy treatment for Thromboangiitis Obliterans: A single center experience

Critical Limb Ischemia due to Buerger Disease Successfully Treated with Endovascular Recanalization and Distal Bypass

Endovascular treatment for thromboangiitis obliterans (Buerger’s disease)

Contact Info

Product

Resources

About